Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 9802: Radiation +/- PCV in Low-Grade Glioma
NCT00003375Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Oct 1998
- Primary completion
- Aug 2005
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
A Phase 3 trial of procarbazine, lomustine, vincristine in glioma, sponsored by NRG Oncology. Started Oct 1998; status: completed.
02
Drugs
procarbazinelomustinevincristine
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00003375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003375.